TIL - Instil Bio, Inc. Stock Price, Fair Value and News

$20.61+0.53 (+2.64%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TIL Price Action

Last 7 days

-6.2%

Last 30 days

-11.8%

Last 90 days

-68.9%

Trailing 12 Months

201.3%

TIL RSI Chart

TIL Valuation

Market Cap

134.5M

Price/Earnings (Trailing)

-1.79

Price/Sales (Trailing)

23.57

EV/EBITDA

-1.37

Price/Free Cashflow

-2.3

TIL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TIL Fundamentals

TIL Revenue

Revenue (TTM)

8.7M

Rev. Growth (Yr)

-28.49%

Rev. Growth (Qtr)

-10.98%

TIL Earnings

Earnings (TTM)

-75.2M

Earnings Growth (Yr)

65.86%

Earnings Growth (Qtr)

-54.33%

TIL Profitability

EBT Margin

-1787.32%

Return on Equity

-42.63%

Return on Assets

-27.58%

Free Cashflow Yield

-43.55%

TIL Investor Care

Shares Dilution (1Y)

0.34%

Diluted EPS (TTM)

-11.56

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	8.7M	0	0	0
2023	5.6M	7.4M	8.5M	0
2022	169.0K	640.0K	1.9M	3.7M
2021	0	109.0K	89.0K	72.0K
2020	0	0	0	138.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Instil Bio, Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

CEO	Mr. Bronson Crouch
WEBSITE	https://instilbio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	192

Instil Bio, Inc. Frequently Asked Questions

What is the ticker symbol for Instil Bio, Inc.? What does TIL stand for in stocks?

TIL is the stock ticker symbol of Instil Bio, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Instil Bio, Inc. (TIL)?

As of Fri Dec 20 2024, market cap of Instil Bio, Inc. is 134.5 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TIL stock?

You can check TIL's fair value in chart for subscribers.

Is Instil Bio, Inc. a good stock to buy?

The fair value guage provides a quick view whether TIL is over valued or under valued. Whether Instil Bio, Inc. is cheap or expensive depends on the assumptions which impact Instil Bio, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TIL.

What is Instil Bio, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, TIL's PE ratio (Price to Earnings) is -1.79 and Price to Sales (PS) ratio is 23.57. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TIL PE ratio will change depending on the future growth rate expectations of investors.